Specific biomarkers of AD can be detected in plasma by analyzing the levels of Aβ 1‐40 (Aβ40), Aβ 1‐42 (Aβ42), and phosphorylated tau (p‐tau). The gene discussed is MAPT; the disease is Alzheimer disease.